Zota Health Care Acquires 21 Lakh Shares in Subsidiary KMHP Ventures
Zota Health Care Limited acquired 21,00,000 equity shares in its wholly-owned subsidiary, KMHP Ventures Limited, for ₹2.10 crore. The investment supports KMHP's retail store expansion under the "Ugo Generic" brand, which will operate on B2B and B2C models.
The acquisition involves a wholly-owned subsidiary and aims to expand its retail business, which is a significant but not transformative event for the parent company.
The acquisition is a strategic investment to expand the subsidiary's retail presence, which is a positive development for the company's growth.
Zota Health Care Limited has announced the acquisition of 21,00,000 equity shares in its wholly-owned subsidiary, KMHP Ventures Limited. The acquisition was made through a subscription to a rights issue at a price of ₹10.00 per equity share, amounting to a total cost of ₹2,10,00,000.
KMHP Ventures Limited is engaged in the pharmaceutical segment and is in the process of launching retail stores under the brand name “Ugo Generic.” This initiative will operate on both Business to Business (B2B) and Business to Consumer (B2C) models, aiming to offer high-quality generic medicines across India. The company plans to onboard approximately 12.5 lakh retail pharmacies under the Ugo Generic brand, alongside its own stores. This strategic investment by Zota Health Care Limited is intended to support the expansion of these retail stores and mitigate the working capital requirements of the subsidiary.
The acquisition does not fall within the scope of related party transactions, and promoter/promoter group/group companies have no interest in KMHP Ventures Limited. The transaction was conducted on an arm's length basis. KMHP Ventures Limited was incorporated on January 13, 2026, and for the Financial Year 2025-26, its reported turnover was NIL. Its current paid-up share capital stands at ₹210.00 lakhs. M/s KMHP Ventures Limited continues to remain a wholly-owned subsidiary of Zota Health Care Limited post-acquisition.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under acquisition. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.